The FDA Approves a Generic form of Copaxone® Thursday, April 16, 2015 The U.S. Food and Drug Administration has approved a generic [...]
People with MS may have trouble recognizing emotions -- MS can damage parts of the brain that allow us to recognize emotions in others. [...]
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of [...]
Teva Neuroscience & Access Health Team Up for Special MS Awareness Show: Thursday, March 5 As Multiple Sclerosis Awareness Week [...]
Multiple sclerosis paroxysmal symptoms can be confused with seizures due to its sudden onset. Paroxysmal symptoms are unique to multiple [...]
An international team of researchers have proposed how vitamin D repairs myelin in multiple sclerosis. This finding could lead to [...]
Acorda Announces Safety and Tolerability Data from First Clinical Trial of Remyelinating Antibody in Multiple Sclerosis Phase 1 trial [...]
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval – Lemtrada now available in the U.S. two weeks post [...]
Genzyme’s Lemtrada Approved by the FDA - Approval Establishes Genzyme’s MS Franchise in the U.S. with Two Approved Products; Follows [...]
Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis Tuesday, November [...]